MAPFRE
Madrid 2,25 EUR 0,02 (0,9 %)
Madrid 2,25 EUR 0,02 (0,9 %)

Home > Executives > Francesco Paolo Vanni D’Archirafi

Organization

Francesco Paolo Vanni d’Archirafi

Personal Details
Full Name

Francesco Paolo Vanni d’Archirafi

Place and date of birth
January 14, 1960, Munich (Germany).
Education:
  • Degree in Finance from American University.
  • MBA in International Finance and Business from Columbia University.
Main Positions:
  • Board Director of MAPFRE.
  • Chairman of the MAPFRE Audit and Compliance Committee.
  • Chairman of the Board of Directors of Euroclear Holding, Euroclear SA/NV and Euroclear Investments.
  • Board Director of MAPFRE INTERNACIONAL.
  • Chairman of the Board of Directors of VERTI ASSICURAZIONI.
Other Positions:
  • Member of the IESE International Advisory Council.
  • President of the International Advisory Council of the KOGOD School of American University.
  • Member of The Board of Trustees of the Centesimus Annus Pro Pontifice Foundation.
  • Trustee de Borne.
  • Trustee del Voluntary Solidarity Fund Internacional.
  • Trustee del The Felix Project.
  • Trustee del United Way Worldwide and United Way UK.
  • Member of the Board of Governors of Junior Achievement Worldwide.
Previous positions:
  • Member of the Board of Directors of Banco Nacional de México, S.A. (2018–2021).
  • Member of the Board of Trustees of the Citigroup Foundation.
  • Vice Chairman of the EMEA Institutional Clients Group at Citigroup Inc. (2018–2021) in London.
  • CEO of Citigroup Holdings (2013–2018) in New York.
  • CEO of Citi Global Transaction Services (2009-2013) in New York.
  • Global Head of Treasury and Foreign Trade Services at Citigroup Inc. (2007-2009).
  • Member of the Board of Directors of LCH Group Holding (2005–2011).
  • Member of the Board of Directors, the Risk Committee and the Nomination and Governance Committee of Private Export Funding Corporation (2013-2018).
Board director category:
  • Independent Board Director.
Dates of appointment as company board director:
  • First appointment: March 10, 2023.

Shares and options for shares held in the company: